QLT Provides Results Of Mont Blanc Study
Canada-based QLT has announced 12-month primary analysis results from the Novartis sponsored phase-II Mont Blanc study . Mont Blanc is the European study of the Novartis sponsored Summit
Genprex has received a notice of allowance from the Canadian Intellectual Property Office (CIPO) for a patent related to the use of its Reqorsa Gene Therapy (quaratusugene ozeplasmid) in combination with either programmed cell death protein 1 (PD-1) or PD-L1 antibodies to treat non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC).
Tata Consultancy Services (TCS) has launched Provider Performance Insight, a business intelligence (BI) software built on SAP BusinessObjects, for hospitals and other healthcare providers. The dashboard has been